跳至主要内容
临床试验/ACTRN12624000188538
ACTRN12624000188538招募中2 期

Hypoxic Enhancement Before Major Surgery (HYPE): A pilot randomised controlled trial of preoperative Roxadustat vs placebo in patients undergoing major surgery, assessing safety, effectiveness and feasibility.

Royal Perth Hospital0 个研究点目标入组 150 人开始时间: 2024年2月27日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Age 18 years or over
  • 2. Undergoing elective major surgery including the following procedures: Oesophagectomy; Gastrectomy; Small bowel resection; Large bowel resection; Hepatectomy; Splenectomy; Pancreatectomy; Nephrectomy; Prostatectomy; Cystectomy; Adrenalectomy; Abdominal aneurysm repair (Open); Femoral-Popliteal Bypass; Total hip replacement; Total knee replacement; Spinal surgery (3 levels or more).

排除标准

  • 1. Inability to provide informed consent
  • 2. Peanut or soya allergy
  • 3. Current viral or bacterial infection
  • 4. Pregnancy or breast feeding
  • 5. Epilepsy
  • 6. Severe liver disease (Childs Pugh C)

研究者

相似试验

A pilot study of preoperative Roxadustat in patients... | 临床试验